II. Background
- Over-the-counter Racemic EpinephrineInhaler used by patients for self-diagnosed bronchospasm
- Replaces Primatene Mist
- Removed from U.S. market in 2011 due to chlorofluorocarbons
- Editorial comment: I thought it was removed for the other right reason (it is dangerous)
III. Disadvantages: Compared with prescribed AlbuterolInhaler
- OTC status bypasses Asthma Evaluation and assessment for controller medications (CorticosteroidInhalers)
- Shorter-acting and less effective than Albuterol
- Increased side effects and more rebound symptoms than Albuterol
- Significant set-up and maintenance of delivery device
- More expensive than Albuterol
IV. References
- (2012) Presc Lett 19(10): 58
- Dickinson (2000) Chest 118:522–526 [PubMed]